| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |